InvestorsHub Logo
Followers 8
Posts 2087
Boards Moderated 0
Alias Born 08/09/2003

Re: Roadtojourney post# 56

Wednesday, 07/03/2019 11:42:07 AM

Wednesday, July 03, 2019 11:42:07 AM

Post# of 149
FDA OKs Karyopharm's selinexor for treatment-resistant multiple myeloma; shares up 36%

Jul. 3, 2019 10:51 AM ET|About: Karyopharm Therapeutic... (KPTI)|By: Douglas W. House, SA News Editor
Karyopharm Therapeutics (KPTI +35.5%) is up on more than a 6x surge in volume in response to the FDA nod for XPOVIO (selinexor) for the treatment of penta-refractory multiple myeloma.

The agency's action date was July 6.
https://seekingalpha.com/news/3475710-fda-oks-karyopharms-selinexor-treatment-resistant-multiple-myeloma-shares-36-percent
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KPTI News